Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-23

Clinical Trial Update: Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP) [Phase 1]

View source ↗

Summary

Phase 1 study assessing the bioavailability of oral OZ439 prototype formulations when administered with Piperaquine Phosphate (PQP) in malaria, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZ439
  • Piperaquine Phosphate (piperaquine phosphate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2015-03-23